RETRACTED: Oroxylin A inhibits carcinogen-induced skin tumorigenesis through inhibition of inflammation by regulating SHCBP1 in mice

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram et al. · CA A Cancer Journal for Clinicians · 2018 · 87.7K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma

Paolo A. Ascierto, Pier Francesco Ferrucci, Rosalie Fisher et al. · Nature Medicine · 2019 · 323 citations

Pharmacy, Oncology, Pharmacotherapy +12

Oroxylin A suppresses the development and growth of colorectal cancer through reprogram of HIF1α-modulated fatty acid metabolism

Ting Ni, Zihao He, Yuanyuan Dai et al. · Cell Death and Disease · 2017 · 87 citations · Full text

Life Sciences, Biochemistry, Oncology +17

α-Mangostin inhibits DMBA/TPA-induced skin cancer through inhibiting inflammation and promoting autophagy and apoptosis by regulating PI3K/Akt/mTOR signaling pathway in mice

Fei Wang, Hongxia Ma, Zhaoguo Liu et al. · Biomedicine & Pharmacotherapy · 2017 · 82 citations

Life Sciences, Oncology, Pharmacology +12

Cryptotanshinone inhibits the growth and invasion of colon cancer by suppressing inflammation and tumor angiogenesis through modulating MMP/TIMP system, PI3K/Akt/mTOR signaling and HIF-1α nuclear translocation

Lin Zhang, Chang Chen, Jiaxin Duanmu et al. · International Immunopharmacology · 2018 · 81 citations

Medicine, Oncology, Pharmacology +17